Sangamo Therapeutics, Inc. (SGMO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 37.11M | 35.83M | 44.08M | 49.89M | 37.6M | 51.69M | 58.13M | 40.08M | 68.64M | 94.33M | 147.58M | 159.61M |
| Cash & Short-Term Investments | 27.59M | 20.95M | 30.53M | 38.34M | 25.18M | 41.92M | 39.2M | 27.79M | 54.42M | 81M | 132.11M | 143.1M |
| Cash Only | 27.59M | 20.95M | 30.53M | 38.34M | 25.18M | 41.92M | 39.2M | 27.79M | 54.42M | 45.2M | 56.51M | 66.83M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.8M | 75.6M | 76.27M |
| Accounts Receivable | 873K | 371K | 5.13M | 4.98M | 4.61M | 4.6M | 10.5M | 581K | 691K | 4.07M | 1.75M | 3.94M |
| Days Sales Outstanding | 38.82 | 17.77 | 799.73 | 23.82 | 64.36 | 91.95 | 10.31 | 162.57 | 450.08 | 131.04 | 27.83 | 79.78 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 8.65M | 14.51M | 8.42M | 6.57M | 7.81M | 5.17M | 8.43M | 11.71M | 13.53M | 9.26M | 13.71M | 12.57M |
| Total Non-Current Assets | 22.85M | 23.91M | 44.57M | 47.66M | 48.57M | 49.94M | 53.13M | 52.94M | 60.33M | 70.99M | 72.12M | 165.47M |
| Property, Plant & Equipment | 13.22M | 0 | 29.22M | 30.79M | 32.84M | 34.76M | 36.91M | 39.29M | 42.95M | 52.87M | 55.65M | 107.49M |
| Fixed Asset Turnover | 0.11x | - | 0.02x | 0.58x | 0.19x | 0.21x | 1.30x | 0.01x | 0.01x | 0.04x | 0.12x | 0.06x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 1.5M | 1.5M | 1.5M | 1.5M | 0 | 0 | 0 | 0 | 39.04M |
| Other Non-Current Assets | 9.63M | 23.91M | 15.35M | 15.37M | 14.23M | 13.69M | 14.72M | 13.65M | 17.37M | 18.13M | 16.47M | 18.94M |
| Total Assets | 59.97M | 59.74M | 88.64M | 97.56M | 86.17M | 101.64M | 111.26M | 93.01M | 128.96M | 165.32M | 219.7M | 325.07M |
| Asset Turnover | 0.02x | 0.19x | 0.01x | 0.20x | 0.07x | 0.07x | 0.48x | 0.00x | 0.00x | 0.01x | 0.03x | 0.02x |
| Asset Growth % | -30.41% | -41.22% | -20.33% | 4.89% | -33.18% | -38.52% | -49.36% | -71.39% | -70.73% | -70.61% | -63.01% | -47.32% |
| Total Current Liabilities | 53.13M | 42.47M | 50.13M | 47.66M | 49.56M | 45.8M | 43.16M | 39.01M | 40.24M | 47.73M | 48.48M | 53.79M |
| Accounts Payable | 19.31M | 14.44M | 15.56M | 10.74M | 18.2M | 15.48M | 19.79M | 17.59M | 15.47M | 15.26M | 15.46M | 14.84M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | 24.41 | 26.69 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 4.31M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 402K | 0 | 7.56M | 7.56M | 7.56M | 7.56M | 774K | 0 | 0 | 0 | 1.49M | 6.87M |
| Other Current Liabilities | 33.42M | 26.33M | 9.87M | 13.94M | 14.01M | 14.57M | 10.96M | 5.04M | 7.47M | 8.92M | 14.23M | 18.96M |
| Current Ratio | 0.70x | 0.84x | 0.88x | 1.05x | 0.76x | 1.13x | 1.35x | 1.03x | 1.71x | 1.98x | 3.04x | 2.97x |
| Quick Ratio | 0.70x | 0.84x | 0.88x | 1.05x | 0.76x | 1.13x | 1.35x | 1.03x | 1.71x | 1.98x | 3.04x | 2.97x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 25.79M | 31.55M | 32.27M | 30.3M | 31.7M | 33.06M | 28.97M | 30.32M | 32.02M | 34.7M | 36.29M | 37.64M |
| Long-Term Debt | 19.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 25.09M | 25.42M | 23.46M | 24.88M | 26.25M | 27.73M | 29.1M | 30.82M | 33.52M | 34.98M | 36.37M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.45M | 6.45M | 977K | 962K | 933K | 933K | 1.24M | 1.22M | 1.21M | 1.19M | 1.32M | 1.27M |
| Total Liabilities | 78.92M | 74.01M | 82.4M | 77.96M | 81.26M | 78.86M | 72.13M | 69.32M | 72.26M | 82.43M | 84.78M | 91.43M |
| Total Debt | 19.33M | 26.8M | 25.42M | 23.46M | 24.88M | 30.57M | 27.73M | 29.1M | 30.82M | 38.1M | 34.98M | 36.37M |
| Net Debt | -8.25M | 5.85M | -5.1M | -14.88M | -304K | -11.35M | -11.47M | 1.31M | -23.6M | -7.1M | -21.54M | -30.46M |
| Debt / Equity | - | - | 4.07x | 1.20x | 5.07x | 1.34x | 0.71x | 1.23x | 0.54x | 0.46x | 0.26x | 0.16x |
| Debt / EBITDA | - | - | - | - | - | - | 2.17x | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | -0.90x | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -18.95M | -14.27M | 6.24M | 19.6M | 4.91M | 22.77M | 39.13M | 23.69M | 56.7M | 82.89M | 134.92M | 233.64M |
| Equity Growth % | -486.36% | -162.66% | -84.05% | -17.26% | -91.35% | -72.53% | -71% | -89.86% | -83.11% | -71.9% | -56.36% | -26.59% |
| Book Value per Share | -0.05 | -0.04 | 0.02 | 0.08 | 0.02 | 0.11 | 0.18 | 0.12 | 0.31 | 0.47 | 0.76 | 1.34 |
| Total Shareholders' Equity | -18.95M | -14.27M | 6.24M | 19.6M | 4.91M | 22.77M | 39.13M | 23.69M | 56.7M | 82.89M | 134.92M | 233.64M |
| Common Stock | 4.14M | 3.51M | 3.22M | 2.73M | 2.25M | 2.13M | 2.09M | 2.08M | 2.04M | 1.78M | 1.77M | 1.77M |
| Retained Earnings | -1.66B | -1.63B | -1.59B | -1.55B | -1.53B | -1.5B | -1.48B | -1.49B | -1.46B | -1.41B | -1.35B | -1.24B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.51M | -1.46M | -1.45M | -1.46M | -5.53M | -7.53M | -4.22M | -5.88M | -5.8M | -4.59M | -6.58M | -5.94M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |